🔎 Trials Near Me

Dachaigh › Melanoma Uveal › Pennsylvania › Philadelphia

Sgrùdaidhean clionaigeach Melanoma Uveal ann an Philadelphia, PA

Tha 7 sgrùdaidhean airson Melanoma Uveal a’ lorg phàirtichean aig làraichean ann agus timcheall air Philadelphia (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma

A’ fastadhÌre 3
  • Wills Eye Hospital at Thomas Jefferson University, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07804186

Tebentafusp-tebn With LDT in Metastatic UM

A’ fastadhÌre 1/2
  • Thomas Jefferson University, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Iuch 2026 · NCT06626516

Neoadjuvant Tebentafusp for Uveal Melanoma

A’ fastadhÌre 2
  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Ògmh 2026 · NCT06414590

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

A’ fastadhÌre 1/2
  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Ògmh 2026 · NCT03947385

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

A’ fastadhÌre 1/2
  • University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
  • Thomas Jefferson University, Honickman Center, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Cèit 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

A’ fastadhÌre 3
  • Jefferson Health Honickman Center, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT07015190

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

A’ fastadhÌre 2/3
  • Thomas Jefferson University, Philadelphia
Gach aois · Gach gnè · Air ùrachadh 2 Gibl 2026 · NCT06581406

Sgrùdaidhean Melanoma Uveal ann am bailtean eile

Sgrùdaidhean eile ann an Philadelphia

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.